MedPage Today -- Hypertensive patients treated with angiotensin-converting enzyme (ACE) inhibitors, angiotensin II-receptor blockers (ARBs), or beta-blockers have a lower risk for atrial fibrillation than those treated with calcium channel blockers, a nested case-control analysis found.
